Elucidation of disease mechanisms underlying rheumatic immune-related adverse events may lead to novel therapeutic strategies for autoimmune diseases
Ann Rheum Dis
.
2022 Dec;81(12):e262.
doi: 10.1136/annrheumdis-2020-217995.
Epub 2020 Aug 7.
Authors
Ryu Watanabe
1
2
,
Motomu Hashimoto
3
2
Affiliations
1
Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan ryuwatanabe@kuhp.kyoto-u.ac.jp.
2
Department of Advanced Medicine for Rheumatic Disease, Kyoto University Graduate School of Medicine, Kyoto, Japan.
3
Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
PMID:
32769155
DOI:
10.1136/annrheumdis-2020-217995
No abstract available
Keywords:
autoimmune diseases; giant cell arteritis; immune system diseases.
Publication types
Letter
Comment
MeSH terms
Autoimmune Diseases* / drug therapy
Humans
Immune System Diseases*
Rheumatic Diseases* / drug therapy